Drug Type Fc fusion protein, Biosimilar |
Synonyms Etanercept biosimilar (Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd.), Recombinant human TNF receptor p75-Fc fusion protein (Shanghai Fudan Zhangjiang Bio Pharmaceutical Co. Ltd.), 重组人肿瘤坏死因子受体-Fc融合蛋白(复旦张江) |
Target |
Action inhibitors |
Mechanism LTα inhibitors(Tumor necrosis factor β inhibitors), TNF-α inhibitors(Tumor necrosis factor α inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
License Organization- |
Drug Highest PhaseDiscontinuedNDA/BLA |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rheumatoid Arthritis | NDA/BLA | China | 12 Jun 2010 | |
Rheumatoid Arthritis | NDA/BLA | China | 12 Jun 2010 |